Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Change in Cash: 2013-2025

Historic Change in Cash for KalVista Pharmaceuticals (KALV) over the last 13 years, with Apr 2025 value amounting to $100.5 million.

  • KalVista Pharmaceuticals' Change in Cash fell 508.44% to -$35.7 million in Q2 2025 from the same period last year, while for Apr 2025 it was -$17.1 million, marking a year-over-year increase of 29.88%. This contributed to the annual value of $100.5 million for FY2025, which is 510.99% up from last year.
  • Latest data reveals that KalVista Pharmaceuticals reported Change in Cash of $100.5 million as of FY2025, which was up 510.99% from -$24.4 million recorded in FY2024.
  • KalVista Pharmaceuticals' Change in Cash's 5-year high stood at $100.5 million during FY2025, with a 5-year trough of -$24.4 million in FY2024.
  • Over the past 3 years, KalVista Pharmaceuticals' median Change in Cash value was $25.5 million (recorded in 2023), while the average stood at $33.8 million.
  • Per our database at Business Quant, KalVista Pharmaceuticals' Change in Cash plummeted by 195.86% in 2024 and then skyrocketed by 510.99% in 2025.
  • KalVista Pharmaceuticals' Change in Cash (Yearly) stood at $34.8 million in 2021, then tumbled by 157.06% to -$19.9 million in 2022, then skyrocketed by 228.43% to $25.5 million in 2023, then crashed by 195.86% to -$24.4 million in 2024, then surged by 510.99% to $100.5 million in 2025.